Over the last several years, Europe has become more open-minded about medical and recreational marijuana. Here are some of the…
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in…
Nasdaq-listed, GH Research GHRS is a clinical-stage biopharma business developing novel 5-MeO-DMT therapies as transformative treatment of psychiatric and neurological…
New Jersey cannabis czar said on Thursday that combined sales of medical and recreational cannabis sales have surpassed $2 billion…
Virginia House Panel Green-Lights Marijuana Bill, Pushes Sales Launch Deadline To Mid-2025 A Virginia House panel green-lighted a revised “compromise”…
Enrollment completed in Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease; topline data…
Axsome Therapeutics Inc AXSM reported fourth-quarter 2023 revenues of $71.53 million, up from $24.37 million a year ago, beating the consensus of…
New York Regulators Intend To Approve Over 100 Cannabis Licenses In Anticipation Of Weed Sales At Madison Square Garden New…
As winter’s chill tightens its grip on the Northern Hemisphere, sun-seekers planning a tropical retreat to the beaches of the…
Thailand: Government Will Ban Recreational Cannabis Use Thailand Public Health Minister Cholnan Srikaew said Tuesday that a new bill banning recreational marijuana is…